ArticleFrontiers in oncology2025
An evaluation of 3D modelling in patients with locally advanced pelvic malignancy undergoing surgical resection.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgery for locally advanced pelvic malignancy is complex, requiring careful operative planning and effective patient consent. Traditional two-dimensional (2D) imaging can limit understanding of tumour-organ relationships for both clinicians and patients. Three-dimensional (3D) reconstructed imaging may have a role in enhancing surgical planning, patient understanding and trainee education. Methods: Adult patients with locally advanced rectal or anal cancer undergoing planned resection at a UK tertiary cancer centre were prospectively identified. CT scans were reconstructed into interactive 3D models using the Visible Patient™ platform. Models were reviewed by surgeons and trainees prior to outpatient consultations and then demonstrated to patients during the consent process. Surgeons, trainees, and patients completed structured questionnaires incorporating Likert-scale responses and free-text feedback. Qualitative data were analysed thematically. Results: Fifteen patient-specific pelvic models were created, with feedback obtained from all surgeons and trainees and from 13 patients. Patient responses were overwhelmingly positive, with median scores of 9-10/10 for realism, understanding of disease and surgery, and perceived benefit during consultation. Thematic analysis highlighted improved understanding, empowerment, and engagement in decision making. Surgeons rated the models moderately for operative planning but highly for trainee education and patient communication. No operative plans were altered following model review. Trainees reported strong educational value, while radiologists noted limitations in segmentation accuracy for intraluminal disease. Conclusion: CT-based 3D reconstructed pelvic models provide substantial benefit in patient education and shared decision making for complex pelvic cancer surgery, with additional value as a training tool. Further studies are warranted to define their role in operative planning and cost-effective implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.